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Embryonic development is a wonderful 
thing to behold. Consider the 
creation of a human embryo: a single 
fertilized egg cell gives rise to an adult 
organism consisting of approximately 
6 × 1013 cells, organized into myriad 
tissues. This amazing feat is achieved 
through a carefully choreographed 
developmental program, where the 
cells of the growing embryo make a 
series of cell fate decisions that guide 
their differentiation into specialized 
tissues.
The first embryonic cell fate decision 
comes early after fertilization, when 
an embryo’s cells differentiate into 
two distinct populations: the inner cell 
mass and the outer trophectoderm. 
The inner cell mass will go on to 
become the embryo proper, while 
trophectoderm cells are stem cells 
that will become the placenta, 
which nourishes and protects the 
developing organism. While the 
genes and pathways contributing to 
embryonic development have enjoyed 
close scientific scrutiny, very little is 
known about how the trophectoderm 
generates placental tissues. In this issue 
of PLoS Biology, Shang-Yi Chiu, Wei 
Hsu, and colleagues uncover a pathway 
that is important for the generation of 
trophectoderm-derived tissues.
The murine placenta comprises 
three layers: the inner labyrinth layer, 
which filters the maternal blood supply 
for nutrients that can be absorbed for 
the embryo; the spongiotrophoblast 
layer, which physically supports the 
labyrinth layer; and an outer layer of 
trophoblast giant cells (TGC), which 
completely surrounds the embryo. 
The TGC cells are unique, because 
they have multiple copies of the 
genome (known as polyploid cells). 
However, when abnormal polyploidy 
(known as aneuploidy) occurs, it 
is associated with cancer. Several 
control mechanisms exist to prevent 
polyploidy; a prominent one is the 
tumor suppressor p53, which acts to 
halt cell growth in the presence of 
DNA damage or other forms of cellular 
stress. However, since the generation 
of polyploid cells in the placenta is part 
of the normal developmental program, 
some mechanism must allow TGC 
cells to evade the controls that prevent 
polyploidy in other tissues.
Chiu and colleagues were led to 
examining placental development by 
their studies on a protein called SENP2, 
which is a member of a family of 
proteases that removes a small protein-
tag called SUMO (short for “small 
ubiquitin-related modifier”) from other 
proteins. SUMO modifies the function 
and subcellular location of proteins to 
which it is attached, and SENP2 helps 
reverse these changes. While studying 
the role of SENP2 in mouse embryonic 
development, the researchers observed 
that SENP2 is specifically expressed 
in trophectoderm-derived tissues, and 
that embryos lacking SENP2 failed 
to properly develop any of the three 
placental tissue layers. This failure 
occurred because the cells that give rise 
to the placental tissues had undergone 
cell cycle arrest and were trapped in a 
state of suspended growth. The authors 
therefore set out to find SENP2 target 
proteins that could be involved in 
arresting cell growth. In the journey 
of their searches, they discovered that 
p53—or proteins that modify p53 
activity—were affected by the SENP2 
deficiency.
Although p53 can be modified by 
SUMO, the group found that SENP2 
indirectly regulates p53 activity in 
trophectoderm-derived tissues by 
modifying the subcellular location 
of another protein called Mdm2. 
Mdm2 is known to interact with p53 
and induce p53 degradation. Mdm2 
can undergo SUMO modification, 
and Chiu and colleagues found that 
SUMO-modified Mdm2 is found only 
in the cell nucleus, not the cytoplasm. 
Cells lacking SENP2 are deficient 
for removing SUMO from Mdm2, 
so Mdm2 becomes trapped in the 
nucleus, where it is unable to promote 
p53 degradation. This allows p53 
to accumulate within the cells, and 
causes cell growth arrest. These effects 
were reversible by knocking down 
p53 expression by RNA interference. 
Furthermore, stimulation of p53 by 
blocking Mdm2 with a drug results in 
defects resembling the loss of SENP2.
These findings have implications 
for both embryonic development and 
cancer. The work highlights a role for 
p53 in preventing polyploidy, because 
p53 repression is required for the 
polyploid trophoblast cells to properly 
develop; the study of trophectoderm-
derived tissues could therefore provide 
further insights into the pathways that 
cells normally use to control polyploidy. 
The authors accordingly plan further 
studies to elucidate how SENP2-
mediated regulation of p53 contributes 
to both normal and pathological cell 
growth processes.
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Placenta for cancer research: What do 
we learn from the first communication 
relay with our mothers? New and old 
players add to our understanding of cells 
with specialized machinery for genome 
replication.
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